HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Novel mouse models for understanding HIV-1 pathogenesis.Methods in molecular biology (Clifton, N.J.) · 2009
   Article
2. Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection.Journal of acquired immune deficiency syndromes (1999) · 2008
   Article
3. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.Journal of virology · 2008
   Article
4. Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.Microbiology and molecular biology reviews : MMBR · 2000
   Review
5. Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice.Proceedings of the National Academy of Sciences of the United States of America · 2000
   Article
6. Virus and target cell evolution in human immunodeficiency virus type 1 infection.Immunologic research · 2000
   Review
7. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.Journal of virology · 1999
   Article
8. Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.Journal of virology · 1999
   Article
9. Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?Immunological reviews · 1998
   Review
10. The Role of the Envelope Glycoprotein in the Depletion of T Helper Cells in Human Immunodeficiency Virus Infection.Pathology oncology research : POR · 1997
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as